Man produces sperm from testicular tissue frozen as a child in breakthrough trial

A groundbreaking fertility trial has successfully restored sperm production in an adult man using testicular tissue that was cryopreserved during his childhood. The 27-year-old patient had testicular tissue frozen at age 10 before undergoing high-dose chemotherapy for sickle cell disease, which threatened his fertility. Sixteen years later, fragments of this tissue were transplanted back into his body, resulting in the production of mature sperm for the first time in such a case. This marks the first documented instance of sperm generation following the re-transplantation of cryopreserved prepubertal testicular tissue. The procedure was led by Professor Ellen Goossens and her team at the Vrije Universiteit Brussel, who have been pioneering this approach since 2002. At that time, the clinic became the first to bank testicular tissue from prepubertal boys, recognizing that traditional sperm preservation methods were not viable before puberty. Immature testes contain spermatogonial stem cells, which can develop into sperm, supported by Sertoli cells. The tissue was surgically removed and frozen prior to the patient’s chemotherapy and bone marrow transplant, which eradicated his own blood cells but also risked permanent infertility. In the recent trial, four tissue fragments were grafted back—some inside the remaining testicle and others under the scrotal skin. After a year, two grafts inside the testicle produced mature sperm, which were collected and frozen for potential future use. Because the grafts are not connected to the natural sperm ducts, sperm are unlikely to appear in the patient’s semen, indicating that assisted reproductive techniques like IVF will be necessary. The findings, published in a preprint pending peer review, offer new hope for childhood cancer and sickle cell patients who face infertility due to life-saving treatments. This breakthrough could transform fertility preservation for prepubertal boys worldwide, a group previously without viable options for biological parenthood after chemotherapy or radiotherapy. Approximately 200 patients annually undergo similar tissue banking at the Belgian clinic, with many now reaching adulthood and seeking ways to start families. The success of this trial may pave the way for wider adoption of testicular tissue freezing and transplantation as a standard fertility preservation method for young patients facing gonadotoxic treatments.